Financing for malaria in the Asia Pacific region has more than quadrupled in the past decade while simultaneously halving the malaria burden. Since 2000, global cases and deaths have also declined by more than 40 % and 60%, respectively. Multiple factors contributed to these reductions including strong political and financial commitment of governments, donors, and partners. However, there has been a steady decline in external financing for malaria, particularly for countries that are middle-income and experience relatively lower transmission of malaria. Although domestic financing for malaria has increased in many countries, the need for malaria control and elimination far exceeds the available resources and investments could be lost if malaria resurges. This presentation will outline these challenges and demonstrate the investment case for malaria elimination in the Asia Pacific region.